RTOG-0129

Terminated

Return to Protocol Table

A Phase III Trial of Concurrent Radiation and Chemotherapy (Followed by Surgery for Residual Primary/N2-3 Nodal Disease) for Advanced Head and Neck Carcinomas

Principal Investigator

Phuc Felix Nguyen-Tan

Status

Terminated

Date Opened To Accrual

July 30, 2002

Date Closed To Accrual

June 23, 2005

Date of Study Termination

May 20, 2022


Disease Site

Head and Neck [HN] Head and Neck

Phase

III

Developmental Therapeutics

No

Primary Objective

To determine whether intensification of radiation, relative to conventional fractionation plus cisplatin in the combined therapy setting can further improve the overall survival of patients with advanced HNSCC.
 

Data Collection Notice:

Data for this trial is being collected via the NRG/RTOG Data Center

Patient Population

Histologic proof of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx

Target Accrual

720

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.


Forms

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.